Global biopharmaceuticals company Biocon has announced its consolidated financial results for the fourth quarter and the fiscal year that ended on March 31, 2023.
The financial impact of the contract will be reflected in the third quarter and fourth quarter of current financial year -- FY24, as well as first quarter of the financial year FY25.
Revenue from operations in the quarter under review surged 8 per cent to Rs 1.33 lakh crore, against Rs 1.23 lakh crore in the corresponding quarter of last year.
According to a statement filed with stock exchanges, the company's total income went down to Rs.335.72 crore during the reviewed period ended March 31, 2023, as compared to Rs.450.1454 crores during the period ended March 31, 2022.
According to the statement from the company, the total income of the firm went down 1 per cent to Rs 60.19 crore, against Rs 60.81 crore in the year-ago period.
The standalone net profit plunged 77.5 per cent year-on-year to Rs 603 crore in the fourth quarter (Q4) against the net profit of Rs 2,683 crore in the year-ago period.
IndiGo continued on the path of profitability as it reported its best-ever fourth-quarter net profit of Rs 9,192 million for the quarter ended March 2023, a 155 per cent jump year-on-year.
Revenues for the quarter ended March 31, 2023, went up 6 per cent to Rs 1,169.2 crore as compared to Rs 1,101.3 crore registered in the fourth quarter ended March 31, 2022
According to a statement from the company, the tyre maker's net revenues went up 22 per cent to Rs 14,681 crore over the figure in the previous year's corresponding period.
Hyderabad (Telangana) [India], May 16 (ANI/PRNewswire): Rainbow Children's Medicare Limited (RCML), a leading multi-specialty pediatric and perinatal care hospital chain in India, has announced its financial results for the fourth quarter and fiscal year ending on March 31st, 2023. The compa